锁骨后与锁骨上臂丛阻滞用于远端上肢手术:随机对照单盲试验
主要结局为注射后30分钟阻滞成功率(复合评分14/16分),两组均为98.3%(P=0.99);锁骨上组穿刺时间更短(5.0 vs 6.0分钟,P=0.006),其余次要结局相似。
要点
- 锁骨后与锁骨上臂丛阻滞30分钟成功率均为98.3%,无差异。
- 锁骨上组平均穿刺时间较锁骨后组缩短1分钟(5.0 vs 6.0分钟)。
- 两组首次阿片请求时间、羟考酮用量及24小时疼痛评分相似。
核心结论
- 超声引导锁骨后与锁骨上臂丛阻滞的成功率相同,镇痛效果相似;锁骨上组穿刺时间缩短无临床相关性。
研究设计与样本
- 两组均使用30 mL 1%甲哌卡因与0.5%罗哌卡因1:1混合液,单次注射技术,不调整针尖位置。
主要发现
- 主要结局阻滞成功率(注射后30分钟复合评分14/16分)锁骨上组98.3%[95%CI:90.8%,99.9%],锁骨后组98.3%[95%CI:90.9%,99.9%],P=0.99。
- 平均穿刺时间锁骨上组5.0分钟[95%CI:4.7,5.4],锁骨后组6.0分钟[95%CI:5.4,6.6],P=0.006。
- 羟考酮消耗量锁骨上组10.0 mg[95%CI:6.5,13.5],锁骨后组7.9 mg[95%CI:4.8,11.0],P=0.80。
- 术后24小时疼痛评分(NRS 0-10)锁骨上组1.2[95%CI:2.1,2.7],锁骨后组1.5[95%CI:1.6,2.4],P=0.09。
关键数值与推荐
- 阻滞成功定义为注射后30分钟复合评分达14/16分(含感觉和运动成分)。
- 两组均采用30 mL 1%甲哌卡因与0.5%罗哌卡因1:1混合液单次注射。
临床怎么用
- 锁骨后与锁骨上臂丛阻滞均可用于远端上肢手术,成功率与镇痛效果相当。
- 锁骨上入路穿刺时间更短,但差异无临床相关性,可依据操作者熟练度选择。
局限性
- 单盲设计,患者对分组可能知晓。
- 单中心研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Regional anaesthesia for upper limb surgery is routinely performed with brachial plexus blocks. A retroclavicular brachial plexus block has recently been described, but has not been adequately compared with another approach. This randomised controlled single-blinded trial tested the hypothesis that the retroclavicular approach, when compared with the supraclavicular approach, would increase the success rate. METHODS: One hundred and twenty ASA physical status 1-3 patients undergoing distal upper limb surgery were randomised to receive an ultrasound-guided retroclavicular or supraclavicular brachial plexus block with 30 mL of a 1:1 mixture of mepivacaine 1% and ropivacaine 0.5%, using a single-injection technique without needle tip repositioning. The primary outcome was block success rate 30 min after local anaesthetic injection, defined as a composite score of 14 of 16 points, inclusive of sensory and motor components. Secondary outcomes included needling time, time to first opioid request, oxycodone consumption, and pain scores (numeric rating scale, 0-10) at 24 h postoperatively. RESULTS: Success rates were 98.3% [95% confidence interval (CI): 90.8%, 99.9%] and 98.3% [95% CI: 90.9%, 99.9%] in the supraclavicular and retroclavicular groups, respectively (P=0.99). The mean needling time was reduced in the supraclavicular group [supraclavicular: 5.0 (95% CI: 4.7, 5.4) min; retroclavicular: 6.0 (95% CI: 5.4, 6.6) min; P=0.006]. The mean time to first opioid request was similar between groups [supraclavicular: 439 (95% CI: 399, 479) min; retroclavicular: 447 (95% CI: 397, 498) min; P=0.19] as were oxycodone consumption [supraclavicular: 10.0 (95% CI: 6.5, 13.5 mg; retroclavicular: 7.9 (95% CI: 4.8, 11.0) mg; P=0.80] and pain scores at 24 h postoperatively [supraclavicular: 1.2 (95% CI: 2.1, 2.7); retroclavicular: 1.5 (95% CI: 1.6, 2.4); P=0.09]. CONCLUSIONS: Ultrasound-guided retroclavicular and supraclavicular brachial plexus blocks share identical success rates, while providing similar pain relief. Reduced needling time in the supraclavicular approach is not clinically relevant. CLINICAL TRIAL REGISTRATION: NCT02641613.
引用
- Grape S, Pawa A, Weber E, et al. Retroclavicular vs supraclavicular brachial plexus block for distal upper limb surgery: a randomised, controlled, single-blinded trial. Br J Anaesth. 2019. PMID: 30857608. doi:10.1016/j.bja.2018.12.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。